Blocking interplay between TERT and c-Myc: a new therapeutic strategy for BRAF V600E /pTERT double mutated tumors
International Journal of Biological Sciences · 2025
DOI: 10.7150/ijbs.111224 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2025. Verfasst von Jing Wei und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, P.R. China. Hauptthemen laut MEDLINE: Telomerase, Proto-Oncogene Proteins B-raf, Proto-Oncogene Proteins c-myc. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Tumors with coexisting mutations of BRAFV600E and TERT promoter (pTERT) are more aggressive and associated with poor patient survival. However, the effective treatments for these tumors are limited, and the mutual regulation mechanism between these two molecules remains largely unclear. Here, we demonstrated that BRAF and TERT could mutually regulate each other, and c-Myc played a vital role in this process. Mechanistically, c-Myc could promote BRAF transcription, and TERT interacted with and stabilized c-Myc. Meanwhile, we verified that c-Myc transcriptionally repressed PP2Ac, which, as the core catalytic subunit of PP2A, leads to dephosphorylation of c-Myc at Ser62, decreasing its stability. These molecular events promoted the progression of BRAFV600E/pTERT double mutated tumors by forming positive regulatory networks. To develop therapeutic strategy for this kind of tumors, we designed two peptides p-CPS62 and CPS62 to break the interaction between TERT and c-Myc, and constructed the corresponding aurous nanoparticles (AuNP-p-CPS62 and AuNP-CPS62). The results showed that AuNP-p-CPS62 and AuNP-CPS62, especially the former, effectively suppressed the growth of BRAFV600E/pTERT double mutated cancer cells both in vitro and vivo, with good biosafety. These findings suggest that blocking the interaction between TERT and c-Myc may be a promising therapeutic option for BRAFV600E/pTERT double mutated tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, P.R. China.
- International Joint Research Center for Tumor Precision Medicine of Shaanxi Province, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, P.R. China.
- Department of Basic Medicine, Shaanxi University of Chinese Medicine, Xianyang 712046, P.R. China.
- BioBank, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, P.R. China.
- Center for Biobank and Advanced Medical Research of Shaanxi Province, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, P.R. China.
- Department of Head and Neck Surgery, Harbin Medical University Cancer Hospital, Harbin 163711, P.R. China.
Zitieren
APA
Wei, J., Liu, J., Zhang, Y., Wang, G., Cui, X., Yu, W., Nie, C., & Hou, P. (2025). Blocking interplay between TERT and c-Myc: a new therapeutic strategy for BRAF V600E /pTERT double mutated tumors. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.111224
Vancouver
Wei J, Liu J, Zhang Y, Wang G, Cui X, Yu W, et al. Blocking interplay between TERT and c-Myc: a new therapeutic strategy for BRAF V600E /pTERT double mutated tumors. International Journal of Biological Sciences. 2025. doi:10.7150/ijbs.111224
BibTeX
@article{Wei2025,
author = {Wei, Jing and Liu, Jiazhe and Zhang, Yan and Wang, Guobin and Cui, Xiao and Yu, Wei and Nie, Chunlei and Hou, Peng},
title = {Blocking interplay between TERT and c-Myc: a new therapeutic strategy for BRAF V600E /pTERT double mutated tumors},
journal = {International Journal of Biological Sciences},
year = {2025},
doi = {10.7150/ijbs.111224}
}
EUVIMED